CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	2002 - 2003
Period Ending	Jul '25 Jul 31, 2025	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	2002 - 2003
Market Capitalization	20	9	17	10	8	-	Upgrade
Market Cap Growth	-	-47.44%	61.67%	29.27%	-	-	Upgrade
Enterprise Value	-	5	16	11	8	-	Upgrade
Last Close Price	2.18	8.20	15.60	13.22	10.23	-	Upgrade
PS Ratio	4.11	1.87	4.03	3.07	3.83	-	Upgrade
PB Ratio	3.34	1.52	2.60	5.24	4.06	-	Upgrade
P/TBV Ratio	4.25	1.94	3.19	6.04	-	-	Upgrade
EV/Sales Ratio	-	1.08	3.92	3.10	3.87	-	Upgrade
EV/EBITDA Ratio	-	-	243.85	93.54	32.62	-	Upgrade
EV/EBIT Ratio	-	-	-	-	24.20	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.01	0.00	-	0.08	Upgrade
Debt / EBITDA Ratio	-	-	0.59	0.04	-	0.46	Upgrade
Asset Turnover	0.65	0.65	0.78	-	-	1.70	Upgrade
Inventory Turnover	3.95	3.95	3.88	-	-	6.01	Upgrade
Quick Ratio	4.09	4.09	4.41	1.79	0.75	1.54	Upgrade
Current Ratio	5.10	5.10	5.26	2.53	3.17	2.17	Upgrade
Return on Equity (ROE)	-10.84%	-10.84%	-10.38%	-	-	18.27%	Upgrade
Return on Assets (ROA)	-6.49%	-6.49%	-1.17%	-	-	4.59%	Upgrade
Return on Capital (ROIC)	-7.70%	-7.70%	-1.47%	-	-	8.67%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	16.90%	11.10%	Upgrade
Earnings Yield	-3.38%	-7.42%	-2.52%	-0.99%	1.14%	-	Upgrade
Dividend Yield	-	-	-	0.36%	-	-	Upgrade
Buyback Yield / Dilution	-108.42%	-	-37.32%	-	-	-11.09%	Upgrade
Total Shareholder Return	-	-	-37.32%	0.36%	-	-11.09%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.